FDA Inspection 812471 — John Agaiby MD
The FDA completed an inspection of John Agaiby MD on March 26, 2013 in Kenosha, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 26, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Kenosha, WI (United States)
Additional Details
Clinical Investigator (CI)